Log in to save to my catalogue

Acute pharmacodynamic responses to sitagliptin: Drug‐induced increase in early insulin secretion in...

Acute pharmacodynamic responses to sitagliptin: Drug‐induced increase in early insulin secretion in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b3cad01e7001482bb125303fa5d0bad4

Acute pharmacodynamic responses to sitagliptin: Drug‐induced increase in early insulin secretion in oral glucose tolerance test

About this item

Full title

Acute pharmacodynamic responses to sitagliptin: Drug‐induced increase in early insulin secretion in oral glucose tolerance test

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical and translational science, 2024-05, Vol.17 (5), p.e13809-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

DPP4 inhibitors are widely prescribed as treatments for type 2 diabetes. Because drug responses vary among individuals, we initiated investigations to identify genetic variants associated with the magnitude of drug responses. Sitagliptin (100 mg) was administered to 47 healthy volunteers. Several endpoints were measured to assess clinically relevan...

Alternative Titles

Full title

Acute pharmacodynamic responses to sitagliptin: Drug‐induced increase in early insulin secretion in oral glucose tolerance test

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b3cad01e7001482bb125303fa5d0bad4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b3cad01e7001482bb125303fa5d0bad4

Other Identifiers

ISSN

1752-8054,1752-8062

E-ISSN

1752-8062

DOI

10.1111/cts.13809

How to access this item